Tag:#Pharmaceutical Cannabis

German Pharmaceutical Firm Enters Cannabis Space With Purchase Of Canopy Growth European Asset

FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth subsidiary C³ Group. C³ specialises...

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025

COMBINED sales of the three most lucrative cannabis pharmaceuticals products - Epidiolex, Dronabinol and Sativex - are set to reach €1.8 billion by 2025,...

Markets: World’s Leading Drug Companies Finding A Way Into Cannabis.

THE emerging cannabis industry is moving up the agenda for the pharmaceutical industry with two significant deals announced in the last few months. Over the...

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read